USS Investment Management Ltd
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1587381
London, X0
Position in REGN
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$13,116,163
-$2,514,344 QoQ
Shares Held
21,035
+4.0% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#260
of 1,322 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026USS Investment Management Ltd holds $177,836,332 across 11 Biotechnology names. REGN ranks #5 (7.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
57,903 | $53,720,666 | |
| 2 | ASND |
Ascendis Pharma A/S
|
141,010 | $37,610,187 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
48,893 | $24,286,619 | |
| 4 | INSM |
INSMED Inc
|
196,253 | $20,924,494 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
21,035 | $13,116,163 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
34,492 | $10,383,126 | |
| 7 | RPRX |
Royalty Pharma plc
|
136,346 | $7,644,920 | |
| 8 | BNTX |
BioNTech SE
|
51,109 | $4,755,692 |
All Filings in REGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,116,163 | 21,035 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $15,630,507 | 20,230 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $14,908,669 | 19,315 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $10,278,295 | 18,280 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $9,597,000 | 18,280 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $11,544,254 | 18,202 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $12,965,830 | 18,202 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $20,648,456 | 19,642 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $20,940,721 | 19,924 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $18,793,579 | 19,526 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $16,796,417 | 19,124 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $16,469,898 | 20,013 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $13,764,352 | 19,156 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $15,532,028 | 18,903 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $13,395,183 | 18,566 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $12,542,944 | 18,208 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $13,922,293 | 23,552 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $17,550,596 | 25,129 | Shares | Sole | 2022-07-18 | |
| 2021-12-31 | $15,315,623 | 24,252 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $14,676,825 | 24,252 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $3,378,049 | 6,048 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $2,861,550 | 6,048 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $2,921,849 | 6,048 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $3,777,395 | 6,748 | Shares | Sole | 2020-10-30 | |
| 2020-06-30 | $4,208,390 | 6,748 | Shares | Sole | 2020-08-11 | |
| No filing history on record for this holder in this stock. | ||||||